Joint Statement on Recall of VONVENDI Lots

Takeda announced the recall of two lots of VONVENDI vonWillebrand factor (recombinant) 1,300 I.U. vials on February 25, 2020. HFA and NHF recognize that recalls can be very unsettling for many in the bleeding disorders community.We are in communications with Takeda to obtain additional detailed and timely information regarding the events that led up to […]